Owner Novartis AG

Inventors Hughes, Thomas Edward; Holmes, David Grenville

Agent Davies Collison Cave

Pub. Number AU-B-2006246483

Parent 2003245903

Filing date 30 November 2006

Wipo publication date 21 December 2006

Acceptance publication date 24 June 2010

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/015 (2006.01)

A61K 31/05 (2006.01)

A61K 31/20 (2006.01)

A61K 31/22 (2006.01)

A61K 31/355 (2006.01)

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 31/375 (2006.01) - Ascorbic acid, i.e. vitamin C

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/405 (2006.01)

A61K 31/4415 (2006.01) - Pyridoxine, i.e.vitamin B

A61K 31/455 (2006.01) - Nicotinic acid, i.e. niacin

A61K 31/616 (2006.01)

A61K 31/714 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system